SCHEMBL14633692

SCHEMBL14633692

Cc1nn(-c2c(Cl)cccc2Cl)c(=O)c2cnc(Nc3cccc(N4CCN(C)CC4)c3)nc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WEE1 P30291 10/20 0.65
▸ CYP3A4 P08684 1/20 0.61
▸ KCNH2 Q12809 2/20 0.53
▸ CCNT1 O60563 4/20 0.52
▸ CCNA2 P20248 4/20 0.52
▸ CDK2 P24941 4/20 0.52
▸ CDK9 P50750 4/20 0.52
▸ NTRK1 P04629 1/20 0.51
▸ NTRK3 Q16288 1/20 0.51
▸ NTRK2 Q16620 1/20 0.51
▸ CDK1 P06493 2/20 0.49
▸ CCNB1 P14635 2/20 0.49
▸ CDK7 P50613 2/20 0.49
▸ CCNH P51946 2/20 0.49
▸ SRC P12931 2/20 0.48
▸ LCK P06239 1/20 0.48
▸ KDR P35968 1/20 0.48
▸ JAK2 O60674 2/20 0.47
▸ BRD4 O60885 2/20 0.47
▸ FGFR1 P11362 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14632992 0.92 WEE1 (0.55) WEE1CYP3A4KCNH2CCNT1CCNA2
SCHEMBL14632964 0.91 WEE1 (0.72) WEE1CYP3A4KCNH2SRCLCK
SCHEMBL14632817 0.91 WEE1 (0.53) WEE1CYP3A4KCNH2CCNT1CCNA2
SCHEMBL14633337 0.91 WEE1 (0.53) WEE1CYP3A4KCNH2CCNT1CCNA2
SCHEMBL14633071 0.90 WEE1 (0.54) WEE1CYP3A4KCNH2CCNT1CCNA2
SCHEMBL14632991 0.89 WEE1 (0.53) WEE1CYP3A4KCNH2CCNT1CCNA2
SCHEMBL14633181 0.89 WEE1 (0.52) WEE1CYP3A4KCNH2CCNT1CCNA2
SCHEMBL14632973 0.88 WEE1 (0.51) WEE1CYP3A4KCNH2CCNT1CCNA2
SCHEMBL14633605 0.88 WEE1 (0.51) WEE1CYP3A4KCNH2CCNT1CCNA2
SCHEMBL14632984 0.87 WEE1 (0.50) WEE1CYP3A4KCNH2CCNT1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 — — US claimed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 — — WO claimed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US claimed
US-9051327-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2015-06-09 — — US disclosed
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBVIE INC (US) 2014-10-02 — — US disclosed
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 — — US disclosed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 — — WO disclosed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 WEE1 1/4885CYP3A4 1925/4885KCNH2 1681/4885
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 WEE1 1/4885CYP3A4 1925/4885KCNH2 1681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback